This is a Validated Antibody Database (VAD) review about rat Msh6, based on 11 published articles (read how Labome selects the articles), using Msh6 antibody in all methods. It is aimed to help Labome visitors find the most suited Msh6 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Knockout validation
BD Biosciences
mouse monoclonal (44/MSH6)
  • western blot knockout validation; mouse; 1:1000; fig 4
BD Biosciences Msh6 antibody (BD Biosciences, 610918) was used in western blot knockout validation on mouse samples at 1:1000 (fig 4). PLoS Genet (2016) ncbi
Abcam
domestic rabbit monoclonal (EPR3945)
  • western blot; human; loading ...; fig e8k
Abcam Msh6 antibody (Abcam, ab92471) was used in western blot on human samples (fig e8k). Nature (2019) ncbi
BD Biosciences
mouse monoclonal (44/MSH6)
  • western blot; human; loading ...; fig 1s1c
BD Biosciences Msh6 antibody (BD, 610918) was used in western blot on human samples (fig 1s1c). elife (2019) ncbi
mouse monoclonal (44/MSH6)
  • immunohistochemistry - paraffin section; human; loading ...; tbl 2
In order to determine the prognostic impact of parameters in peritoneal carcinomatosis from colorectal cancer, BD Biosciences Msh6 antibody (BD Transduction Laboratories, 44/MSH6) was used in immunohistochemistry - paraffin section on human samples (tbl 2). Am J Surg (2017) ncbi
mouse monoclonal (44/MSH6)
  • western blot knockout validation; mouse; 1:1000; fig 4
BD Biosciences Msh6 antibody (BD Biosciences, 610918) was used in western blot knockout validation on mouse samples at 1:1000 (fig 4). PLoS Genet (2016) ncbi
mouse monoclonal (44/MSH6)
  • immunohistochemistry; human; 1:800; fig s4b
In order to discuss mechanisms involved in the resistance of androgen receptor-targeted therapies, BD Biosciences Msh6 antibody (BD Biosciences, 610919) was used in immunohistochemistry on human samples at 1:800 (fig s4b). Nat Med (2016) ncbi
mouse monoclonal (44/MSH6)
  • immunohistochemistry; human; 1:100; loading ...
BD Biosciences Msh6 antibody (BD Pharmingen, 44) was used in immunohistochemistry on human samples at 1:100. JAMA Oncol (2016) ncbi
mouse monoclonal (44/MSH6)
  • western blot; mouse; 1:2500; loading ...; fig 4a
In order to study the role of Pms2 ATPase domain in male fertility, BD Biosciences Msh6 antibody (BD Biosciences, 610918) was used in western blot on mouse samples at 1:2500 (fig 4a). DNA Repair (Amst) (2016) ncbi
mouse monoclonal (44/MSH6)
  • immunohistochemistry; human; 1:200
BD Biosciences Msh6 antibody (BD Transduction Laboratories, 44/MSH6) was used in immunohistochemistry on human samples at 1:200. Virchows Arch (2015) ncbi
mouse monoclonal (44/MSH6)
  • immunohistochemistry - paraffin section; human
BD Biosciences Msh6 antibody (BD Pharmingen, 610919) was used in immunohistochemistry - paraffin section on human samples . Cancer Genet (2014) ncbi
mouse monoclonal (44/MSH6)
  • immunohistochemistry; human; 1:100; fig 1
In order to identify and characterize BRAF mutation from patients with metanephric adenomas, BD Biosciences Msh6 antibody (BD Biosciences, 44/MSH6) was used in immunohistochemistry on human samples at 1:100 (fig 1). Cancer Genet (2013) ncbi
mouse monoclonal (44/MSH6)
  • immunocytochemistry; human
  • western blot; human
BD Biosciences Msh6 antibody (BD Bioscience, 610919) was used in immunocytochemistry on human samples and in western blot on human samples . PLoS ONE (2013) ncbi
Articles Reviewed
  1. Pech M, Fong L, Villalta J, Chan L, Kharbanda S, O Brien J, et al. Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance. elife. 2019;8: pubmed publisher
  2. Wang J, Liu Y, Liu Y, Zheng S, Wang X, Zhao J, et al. Time-resolved protein activation by proximal decaging in living systems. Nature. 2019;569:509-513 pubmed publisher
  3. Massalou D, Benizri E, Chevallier A, Duranton Tanneur V, Pedeutour F, Benchimol D, et al. Peritoneal carcinomatosis of colorectal cancer: novel clinical and molecular outcomes. Am J Surg. 2017;213:377-387 pubmed publisher
  4. Zhao X, Lokanga R, Allette K, Gazy I, Wu D, Usdin K. A MutS?-Dependent Contribution of MutS? to Repeat Expansions in Fragile X Premutation Mice?. PLoS Genet. 2016;12:e1006190 pubmed publisher
  5. Beltran H, Prandi D, Mosquera J, Benelli M, Puca L, Cyrta J, et al. Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. Nat Med. 2016;22:298-305 pubmed publisher
  6. Taieb J, Zaanan A, Le Malicot K, Julie C, Blons H, Mineur L, et al. Prognostic Effect of BRAF and KRAS Mutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab: A Post Hoc Analysis of the PETACC-8 Trial. JAMA Oncol. 2016;2:643-653 pubmed publisher
  7. Fischer J, Dudley S, Miller A, Liskay R. An intact Pms2 ATPase domain is not essential for male fertility. DNA Repair (Amst). 2016;39:46-51 pubmed publisher
  8. Vanoli A, Argenti F, Vinci A, La Rosa S, Viglio A, Riboni R, et al. Hepatoid carcinoma of the pancreas with lymphoid stroma: first description of the clinical, morphological, immunohistochemical, and molecular characteristics of an unusual pancreatic carcinoma. Virchows Arch. 2015;467:237-45 pubmed publisher
  9. Vilar E, Mork M, Cuddy A, Borràs E, Bannon S, Taggart M, et al. Role of microsatellite instability-low as a diagnostic biomarker of Lynch syndrome in colorectal cancer. Cancer Genet. 2014;207:495-502 pubmed publisher
  10. Dadone B, Ambrosetti D, Carpentier X, Duranton Tanneur V, Burel Vandenbos F, Amiel J, et al. A renal metanephric adenoma showing both a 2p16e24 deletion and BRAF V600E mutation: a synergistic role for a tumor suppressor gene on chromosome 2p and BRAF activation?. Cancer Genet. 2013;206:347-52 pubmed
  11. Gupte M, Tuck A, Sharma V, Williams K. Major differences between tumor and normal human cell fates after exposure to chemotherapeutic monofunctional alkylator. PLoS ONE. 2013;8:e74071 pubmed publisher